|
44
|
138
|
9ixuA |
Overall reconstruction of the bax line |
|
58
|
158
|
9o16A |
Crystal structure of human bcl-2 (r129l) mutant in complex with a stapled bad bh3 peptide bad sahb 4.2 |
|
6
|
21
|
9o16B |
Crystal structure of human bcl-2 (r129l) mutant in complex with a stapled bad bh3 peptide bad sahb 4.2 |
|
6
|
21
|
9o15B |
Crystal structure of bcl-2 (g101v) mutant in complex with a stapled bad bh3 peptide bad sahb 4.2 |
|
6
|
21
|
9o14B |
Crystal structure of bcl-2 in complex with a stapled bad bh3 peptide bad sahb 4.2 |
|
54
|
157
|
9o14A |
Crystal structure of bcl-2 in complex with a stapled bad bh3 peptide bad sahb 4.2 |
|
56
|
155
|
9o15A |
Crystal structure of bcl-2 (g101v) mutant in complex with a stapled bad bh3 peptide bad sahb 4.2 |
|
58
|
150
|
9efjA |
Irreversible mcl-1/hit2 complex |
|
31
|
98
|
9r44A |
Crystal structure of human caspase-9 card |
|
3
|
11
|
9z3vC |
Histidine-covalent 165g1 targeting hmcl-1 |
|
58
|
153
|
9z3vA |
Histidine-covalent 165g1 targeting hmcl-1 |
|
41
|
217
|
9ohhH |
Crystal structure of the therapeutic anti-netrin-1 antibody np137 |
|
38
|
221
|
9ohhL |
Crystal structure of the therapeutic anti-netrin-1 antibody np137 |
|
31
|
107
|
9vgdA |
Helical assembly of tradd death domain |
|
30
|
100
|
9vini |
Ternary complex of tnfr1-dd, tradd-dd and ripk1-dd |
|
30
|
107
|
9vinE |
Ternary complex of tnfr1-dd, tradd-dd and ripk1-dd |
|
27
|
87
|
9vinA |
Ternary complex of tnfr1-dd, tradd-dd and ripk1-dd |
|
13
|
106
|
9vjlA |
Phosphorylation dependent recognition of ripk1 by phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 |
|
0
|
16
|
9vjlB |
Phosphorylation dependent recognition of ripk1 by phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 |
|
55
|
149
|
9s6mA |
Structure of bfl1 in complex with a covalent inhibitor, alternative series, cmpd25 |
|
43
|
245
|
9h5mA |
Cryo-em structure of gasdermin-e |
|
20
|
53
|
9nltA |
Crystal structure of flpp3-minibinder687 complex |
|
30
|
106
|
9nltB |
Crystal structure of flpp3-minibinder687 complex |
|
34
|
214
|
9cphL |
Structural basis of bak sequestration by mcl-1 and consequences for apoptosis initiation |
|
9
|
21
|
9cphB |
Structural basis of bak sequestration by mcl-1 and consequences for apoptosis initiation |
|
58
|
167
|
9cpeA |
Structural basis of bak sequestration by mcl-1 and consequences for apoptosis initiation |
|
36
|
230
|
9cphH |
Structural basis of bak sequestration by mcl-1 and consequences for apoptosis initiation |
|
9
|
22
|
9cpfE |
Structural basis of bak sequestration by mcl-1 and consequences for apoptosis initiation |
|
140
|
515
|
9cphA |
Structural basis of bak sequestration by mcl-1 and consequences for apoptosis initiation |
|
177
|
516
|
9cpnA |
Structural basis of bak sequestration by mcl-1 and consequences for apoptosis initiation |
|
185
|
516
|
9cpfA |
Structural basis of bak sequestration by mcl-1 and consequences for apoptosis initiation |
|
8
|
22
|
9cpnE |
Structural basis of bak sequestration by mcl-1 and consequences for apoptosis initiation |
|
55
|
149
|
9ew8A |
Discovery of a series of covalent, cell active bfl-1 inhibitors |
|
54
|
148
|
9gipA |
Bfl1 covalently bound to inhibitor compound 7 |
|
56
|
147
|
9gisA |
Bfl1 covalently bound to inhibitor compound 17 |
|
58
|
147
|
9girA |
Bfl1 covalently bound to inhibitor compound 39 |
|
54
|
148
|
9giqA |
Bfl1 covalently bound to inhibitor compound 13 |
|
56
|
149
|
9gitA |
Bfl1 covalently bound to inhibitor compound 43 |
|
33
|
112
|
9j5gA |
Autophagy-related proteins of magnaporthe oryzae-moatg8 |
|
104
|
242
|
9g2rA |
Endophilin b1 dimers bound to nanodiscs |
|
104
|
242
|
9g2uA |
Endophilin b1 dimer bound to nanodisc center |
|
32
|
102
|
8y6qA |
Structure of the dark/dronc complex |
|
175
|
516
|
9bcgA |
Myeloid cell leukemia-1 (mcl-1) complexed with compound |
|
105
|
242
|
9g2wA |
Endophilin b1 dimer bound to nanodisc edge |
|
54
|
147
|
8rpoA |
Bfl1 in complex with a reversible covalent ligand |
|
187
|
518
|
8t6fA |
Crystal structure of human mbp-myeloid cell leukemia 1 (mcl-1) in complex with brd810 inhibitor |
|
56
|
147
|
9fkyA |
Discovery of a series of covalent, cell active bfl-1 inhibitors |
|
50
|
151
|
9fkzA |
Discovery of a series of covalent, cell active bfl-1 inhibitors |
|
54
|
149
|
9fl0A |
Discovery of a series of covalent, cell active bfl-1 inhibitors |
|
55
|
153
|
9cknA |
Histidine-covalent alpha-helical peptide (compound 6) targeting hmcl-1 |
